Chimeric Therapeutics Limited

About Cell Therapy

Team

T Cell Derived Autologous Therapies

Pipeline

NK Cell Derived Allogeneic Therapies

Science

Governance

Announcements

Updates

New investors

Investor Hub

Home

About Us

DM Sans

Click here to visit our dedicated Entitlement Offer (NREO) page for all the information you need to participate. 

Cell therapy is the transfer of intact, live cells into a patient to help lessen or cure a disease. 

The most common and simple type of cell therapy is a blood transfusion. Other commonly known cell therapies include red and white blood cell transfusions and bone marrow transplants. 

When the cells that are used for the therapy originate from the patient it is referred to as an autologous cell therapy.

When the cells that are used for the therapy originate from a donor it is referred to as an allogeneic cell therapy.

Autologous Chimeric Antigen Receptor (CAR) T cell therapy is a type of cell therapy in which a patient’s own T cells are reprogrammed in a laboratory to attack specific cancer cells.

CAR T cell therapies have shown transformative benefit in patients with blood cancers that have not responded or stopped responding to other therapies resulting in global approvals for CAR T cell therapies for certain types of Lymphoma, Leukemia and Multiple Myeloma.